These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 10716661)
1. Recent insights into the molecular pathogenesis of Huntington disease. Leavitt BR; Wellington CL; Hayden MR Semin Neurol; 1999; 19(4):385-95. PubMed ID: 10716661 [TBL] [Abstract][Full Text] [Related]
2. Recent advances on the pathogenesis of Huntington's disease. Petersén A; Mani K; Brundin P Exp Neurol; 1999 May; 157(1):1-18. PubMed ID: 10222105 [TBL] [Abstract][Full Text] [Related]
3. Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models. Schilling G; Klevytska A; Tebbenkamp AT; Juenemann K; Cooper J; Gonzales V; Slunt H; Poirer M; Ross CA; Borchelt DR J Neuropathol Exp Neurol; 2007 Apr; 66(4):313-20. PubMed ID: 17413322 [TBL] [Abstract][Full Text] [Related]
4. Huntington disease: new insights on the role of huntingtin cleavage. Wellington CL; Leavitt BR; Hayden MR J Neural Transm Suppl; 2000; (58):1-17. PubMed ID: 11128600 [TBL] [Abstract][Full Text] [Related]
5. Selective degeneration in YAC mouse models of Huntington disease. Van Raamsdonk JM; Warby SC; Hayden MR Brain Res Bull; 2007 Apr; 72(2-3):124-31. PubMed ID: 17352936 [TBL] [Abstract][Full Text] [Related]
6. Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease. Hannan AJ Acta Biochim Pol; 2004; 51(2):415-30. PubMed ID: 15218539 [TBL] [Abstract][Full Text] [Related]
7. The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease. Gil JM; Rego AC Brain Res Rev; 2009 Mar; 59(2):410-31. PubMed ID: 19118572 [TBL] [Abstract][Full Text] [Related]
8. Partial depletion of CREB-binding protein reduces life expectancy in a mouse model of Huntington disease. Klevytska AM; Tebbenkamp AT; Savonenko AV; Borchelt DR J Neuropathol Exp Neurol; 2010 Apr; 69(4):396-404. PubMed ID: 20448484 [TBL] [Abstract][Full Text] [Related]
10. [The role of mitochondria in the pathogenesis of Huntington's disease]. Karachitos A; Gałgańska H; Kmita H Postepy Biochem; 2010; 56(2):174-81. PubMed ID: 20873112 [TBL] [Abstract][Full Text] [Related]
12. In vivo proof-of-concept of removal of the huntingtin caspase cleavage motif-encoding exon 12 approach in the YAC128 mouse model of Huntington's disease. Casaca-Carreira J; Toonen LJA; Evers MM; Jahanshahi A; van-Roon-Mom WMC; Temel Y Biomed Pharmacother; 2016 Dec; 84():93-96. PubMed ID: 27639545 [TBL] [Abstract][Full Text] [Related]
14. Huntington disease: new insights into the relationship between CAG expansion and disease. Nasir J; Goldberg YP; Hayden MR Hum Mol Genet; 1996; 5 Spec No():1431-5. PubMed ID: 8875248 [TBL] [Abstract][Full Text] [Related]
15. Partial rescue of some features of Huntington Disease in the genetic absence of caspase-6 in YAC128 mice. Wong BKY; Ehrnhoefer DE; Graham RK; Martin DDO; Ladha S; Uribe V; Stanek LM; Franciosi S; Qiu X; Deng Y; Kovalik V; Zhang W; Pouladi MA; Shihabuddin LS; Hayden MR Neurobiol Dis; 2015 Apr; 76():24-36. PubMed ID: 25583186 [TBL] [Abstract][Full Text] [Related]